German pharmaceutical company Boehringer Ingelheim is setting up an international injectables center in Barcelona, Spain, according to Spanish newspaper Cinco Dias. The company says that the site will be one of its four key centers in Europe
The center will be operational in 1998 and will be completed in two phases. The first stage will include the construction of a new plant, which is due to start this month, on a budget of 12 billion pesetas ($96.7 million). Almost half of this figure will be invested in technology.
At Sant Cugat near Barcelona, the firm will also manufacture capsules, ampoules and other vials. Production will be 37 million units annually on 70% manufacturing capacity.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze